grepcent public filings, reorganized for comparison

Peer reviews

AI-assembled from public SEC filings

Auto OEMs peer review

Descriptive comparison assembled from public SEC filings and verified companyfacts.

Descriptive comparison — not investment advice. This feature-specific review is assembled from a frozen evidence pack of public SEC filing quotes and verified SEC companyfacts numbers. It is descriptive only and makes no judgment about which company is better. It is not a rating, recommendation, endorsement, forecast, or investment advice. Figures are as of their cited filing dates. See Disclaimer.

Methodology

Mechanical auto-OEM cluster: cached large motor-vehicle manufacturers in grepcent's processed universe with SEC SIC 3711 Motor Vehicles and Passenger Car Bodies, constrained to the requested available members. STLA was requested but is not present in the processed cache.

The cluster is selected from cached SEC SIC 3711 companies and kept to the requested large OEM peer tier: GM, F, and TSLA. TSLA's pure-EV/high-growth model differs from legacy GM and F; that divergence is descriptive rather than a claim of identical business models. For GM and F, liabilities/equity is quarantined because total-company leverage includes captive-finance arms (GM Financial and Ford Credit) and is not comparable to industrial-only auto leverage. STLA is missing from the processed cache and is not fabricated.

Pack hash: a3bd060ed3a711b309cb8f1d5e2c2f9f9437b08ed63c629cd5caad9a6a3727c3. Generated: 2026-06-27.

Verified Quantitative Matrix

Numbers are templated from frozen SEC companyfacts-derived facts already verified by grepcent. Fiscal periods and filing dates are shown in each cell; comparability markers use day-level period ends and reported XBRL source concepts.

MetricGMFTSLA
Revenue
Mixed reporting concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues. Ticker concepts: F -> us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; GM -> us-gaap:Revenues; TSLA -> us-gaap:Revenues.
185,019,000,000
FY 2025; period end 2025-12-31; filed 2026-01-27; reporting currency USD
source · NUM_GM_REVENUE_FY2025
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
187,267,000,000
FY 2025; period end 2025-12-31; filed 2026-02-11; reporting currency USD
source · NUM_F_REVENUE_FY2025
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
94,827,000,000
FY 2025; period end 2025-12-31; filed 2026-01-29; reporting currency USD
source · NUM_TSLA_REVENUE_FY2025
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
Gross margin
Mixed reporting concepts: us-gaap:CostOfGoodsAndServicesSold, us-gaap:GrossProfit, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues. Ticker concepts: F -> us-gaap:CostOfGoodsAndServicesSold + us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; TSLA -> us-gaap:GrossProfit + us-gaap:Revenues.
Not available.6.84%
FY 2025; period end 2025-12-31; filed 2026-02-11
source · NUM_F_GROSS_MARGIN_FY2025
grepcent-computed in code: (revenue - cost of revenue) / revenue from NUM_F_REVENUE_FY2025, NUM_F_COST_OF_REVENUE_FY2025.
Computed from filing inputs; may differ from the company's own reported/adjusted ratio.
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
18.03%
FY 2025; period end 2025-12-31; filed 2026-01-29
source · NUM_TSLA_GROSS_MARGIN_FY2025
grepcent-computed in code: gross profit / revenue from NUM_TSLA_GROSS_PROFIT_FY2025, NUM_TSLA_REVENUE_FY2025.
Computed from filing inputs; may differ from the company's own reported/adjusted ratio.
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
Operating margin
Mixed reporting concepts: us-gaap:OperatingIncomeLoss, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues. Ticker concepts: F -> us-gaap:OperatingIncomeLoss + us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; GM -> us-gaap:OperatingIncomeLoss + us-gaap:Revenues; TSLA -> us-gaap:OperatingIncomeLoss + us-gaap:Revenues.
1.57%
FY 2025; period end 2025-12-31; filed 2026-01-27
source · NUM_GM_OPERATING_MARGIN_FY2025
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
-4.90%
FY 2025; period end 2025-12-31; filed 2026-02-11
source · NUM_F_OPERATING_MARGIN_FY2025
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
4.59%
FY 2025; period end 2025-12-31; filed 2026-01-29
source · NUM_TSLA_OPERATING_MARGIN_FY2025
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
Net margin
Mixed reporting concepts: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues. Ticker concepts: F -> us-gaap:ProfitLoss + us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; GM -> us-gaap:NetIncomeLoss + us-gaap:Revenues; TSLA -> us-gaap:NetIncomeLoss + us-gaap:Revenues.
1.46%
FY 2025; period end 2025-12-31; filed 2026-01-27
source · NUM_GM_NET_MARGIN_FY2025
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
-4.36%
FY 2025; period end 2025-12-31; filed 2026-02-11
source · NUM_F_NET_MARGIN_FY2025
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
4.00%
FY 2025; period end 2025-12-31; filed 2026-01-29
source · NUM_TSLA_NET_MARGIN_FY2025
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
R&D expenseNot available.9,400,000,000
FY 2025; period end 2025-12-31; filed 2026-02-11; reporting currency USD
source · NUM_F_RESEARCH_AND_DEVELOPMENT_FY2025
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
6,411,000,000
FY 2025; period end 2025-12-31; filed 2026-01-29; reporting currency USD
source · NUM_TSLA_RESEARCH_AND_DEVELOPMENT_FY2025
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
R&D / revenue
Mixed reporting concepts: us-gaap:ResearchAndDevelopmentExpense, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues. Ticker concepts: F -> us-gaap:ResearchAndDevelopmentExpense + us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; TSLA -> us-gaap:ResearchAndDevelopmentExpense + us-gaap:Revenues.
Not available.5.02%
FY 2025; period end 2025-12-31; filed 2026-02-11
source · NUM_F_R_AND_D_INTENSITY_FY2025
grepcent-computed in code: research and development expense / revenue from NUM_F_RESEARCH_AND_DEVELOPMENT_FY2025, NUM_F_REVENUE_FY2025.
Computed from filing inputs; may differ from the company's own reported/adjusted ratio.
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
6.76%
FY 2025; period end 2025-12-31; filed 2026-01-29
source · NUM_TSLA_R_AND_D_INTENSITY_FY2025
grepcent-computed in code: research and development expense / revenue from NUM_TSLA_RESEARCH_AND_DEVELOPMENT_FY2025, NUM_TSLA_REVENUE_FY2025.
Computed from filing inputs; may differ from the company's own reported/adjusted ratio.
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
Capital expenditures
Mixed reporting concepts: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Ticker concepts: F -> us-gaap:PaymentsToAcquireProductiveAssets; GM -> us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; TSLA -> us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
9,303,000,000
FY 2025; period end 2025-12-31; filed 2026-01-27; reporting currency USD
source · NUM_GM_CAPEX_FY2025
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
8,815,000,000
FY 2025; period end 2025-12-31; filed 2026-02-11; reporting currency USD
source · NUM_F_CAPEX_FY2025
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
8,527,000,000
FY 2025; period end 2025-12-31; filed 2026-01-29; reporting currency USD
source · NUM_TSLA_CAPEX_FY2025
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
Capex / revenue
Mixed reporting concepts: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues. Ticker concepts: F -> us-gaap:PaymentsToAcquireProductiveAssets + us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; GM -> us-gaap:PaymentsToAcquirePropertyPlantAndEquipment + us-gaap:Revenues; TSLA -> us-gaap:PaymentsToAcquirePropertyPlantAndEquipment + us-gaap:Revenues.
5.03%
FY 2025; period end 2025-12-31; filed 2026-01-27
source · NUM_GM_CAPEX_INTENSITY_FY2025
grepcent-computed in code: capital expenditures / revenue from NUM_GM_CAPEX_FY2025, NUM_GM_REVENUE_FY2025.
Computed from filing inputs; may differ from the company's own reported/adjusted ratio.
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
4.71%
FY 2025; period end 2025-12-31; filed 2026-02-11
source · NUM_F_CAPEX_INTENSITY_FY2025
grepcent-computed in code: capital expenditures / revenue from NUM_F_CAPEX_FY2025, NUM_F_REVENUE_FY2025.
Computed from filing inputs; may differ from the company's own reported/adjusted ratio.
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
8.99%
FY 2025; period end 2025-12-31; filed 2026-01-29
source · NUM_TSLA_CAPEX_INTENSITY_FY2025
grepcent-computed in code: capital expenditures / revenue from NUM_TSLA_CAPEX_FY2025, NUM_TSLA_REVENUE_FY2025.
Computed from filing inputs; may differ from the company's own reported/adjusted ratio.
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
Free cash flow
Mixed reporting concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities, us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Ticker concepts: F -> us-gaap:NetCashProvidedByUsedInOperatingActivities + us-gaap:PaymentsToAcquireProductiveAssets; GM -> us-gaap:NetCashProvidedByUsedInOperatingActivities + us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; TSLA -> us-gaap:NetCashProvidedByUsedInOperatingActivities + us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
17,564,000,000
FY 2025; period end 2025-12-31; filed 2026-01-27; reporting currency USD
source · NUM_GM_FREE_CASH_FLOW_FY2025
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
12,467,000,000
FY 2025; period end 2025-12-31; filed 2026-02-11; reporting currency USD
source · NUM_F_FREE_CASH_FLOW_FY2025
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
6,220,000,000
FY 2025; period end 2025-12-31; filed 2026-01-29; reporting currency USD
source · NUM_TSLA_FREE_CASH_FLOW_FY2025
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
Liabilities / equity leverageQuarantined: Quarantined for comparability: GM and F total-company liabilities include captive-finance arms (GM Financial and Ford Credit), so liabilities/equity is not comparable to TSLA's industrial balance sheet without a clean automotive-only split.
Cash and equivalents20,945,000,000
FY 2025; period end 2025-12-31; filed 2026-01-27; reporting currency USD
source · NUM_GM_CASH_FY2025
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
23,356,000,000
FY 2025; period end 2025-12-31; filed 2026-02-11; reporting currency USD
source · NUM_F_CASH_FY2025
Day-level period offset: 0d vs row reference 2025-12-31; aligned.
16,513,000,000
FY 2025; period end 2025-12-31; filed 2026-01-29; reporting currency USD
source · NUM_TSLA_CASH_FY2025
Day-level period offset: 0d vs row reference 2025-12-31; aligned.

Code-computed comparisons

Market-risk companion: risk and factor comparison from lmfin. It is descriptive and separate from the SEC fundamentals review.

Narrative Matrix

DimensionGMFTSLA
Business modelQuarantined: no direct dimension-relevant quote survived the gate.

In its latest annual MD&A, F describes this business model item. [FACT:Q_F_BUSINESS_MODEL_1]

For example, in Ford Blue, our larger, more profitable vehicles had an average contribution margin that was 153% of our total average contribution margin across all vehicles, whereas our smaller vehicles had significantly lower contribution margins.

company page · source filing · fact Q_F_BUSINESS_MODEL_1 · filed 2026-02-11

Quarantined: no direct dimension-relevant quote survived the gate.
Geographic and customer exposureQuarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.
Capital allocationQuarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.
Stated strategy in filingsQuarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.

In its latest annual MD&A, TSLA describes this stated strategy in filings item. [FACT:Q_TSLA_STATED_STRATEGY_1]

We continue to ramp production and build and optimize our manufacturing capacity, expand our operations while focusing on further cost reductions and operational efficiencies to enable increased deliveries and deployments of our products, and invest in research and development to accelerate our AI, software and fleet-based profits for further revenue growth.

company page · source filing · fact Q_TSLA_STATED_STRATEGY_1 · filed 2026-01-29

Idiosyncratic risks in filings

In its latest annual MD&A, GM describes this idiosyncratic risks in filings item. [FACT:Q_GM_IDIOSYNCRATIC_RISKS_3]

Through its leasing program GM Financial is exposed to residual values, which are heavily dependent on used vehicle prices.

company page · source filing · fact Q_GM_IDIOSYNCRATIC_RISKS_3 · filed 2026-01-27

In its latest annual MD&A, F describes this idiosyncratic risks in filings item. [FACT:Q_F_IDIOSYNCRATIC_RISKS_1]

Most of the vehicles sold by us to our dealers and distributors are financed at wholesale by Ford Credit.

company page · source filing · fact Q_F_IDIOSYNCRATIC_RISKS_1 · filed 2026-02-11

Quarantined: no direct dimension-relevant quote survived the gate.
Recent narrative changeQuarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.Quarantined: no direct dimension-relevant quote survived the gate.

Gate summary

Facts: 35. Claims survived: 4. Claims dropped: 0. Cells quarantined: 14.

Quarantined quantitative rows

Quarantined dimensions

Quarantined cells